Prolongation of tumour volume doubling time (midDT) is associated with improvement in disease-specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapy
| Image |  |
|---|---|
| Description | scientific article published on 21 February 2019 |
| Author/s |
author: Mona M Sabra |
| Publication date | February 21, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |